Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03220880 · ClinicalTrials.gov registry record
Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 578
- Enrollment target
NCT03220880 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 578 participants.
The verdict
NCT03220880 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 578 participants
- Enrollment target
Study Summary
Specific Aim 1: To describe the adequacy of sedation associated with different regimens of IN DEX in children undergoing non-painful procedures. This aim will test the working hypothesis that IN DEX regimens are effective for producing sedation adequate for completion of non-painful procedures in children. Specific Aim 2: To describe the temporal characteristics associated with varied regimens of IN DEX in children undergoing non-painful procedures, such as time to onset of adequate sedation; time to procedure start; and time from procedure end to meeting discharge criteria. This aim will test the working hypothesis that IN DEX regimens have temporal characteristics that are favourable for sedating children for non-painful procedures. Specific Aim 3: To describe the adverse events associated with varied regimens of IN DEX in children undergoing non-painful procedures. This aim will test the working hypothesis that IN DEX regimens have a low incidence of adverse events.
Interventions
- DRUG Intranasal dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2020-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03220880
The ClinicalTrials.gov registry entry for NCT03220880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 578 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intranasal dexmedetomidine is the first listed.
NCT03220880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03220880 about?
NCT03220880 is a clinical study titled "Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures". Specific Aim 1: To describe the adequacy of sedation associated with different regimens of IN DEX in children undergoing non-painful procedures. This aim will test the working hypothesis that IN DEX regimens are effective for producing sedation adequate for completion of non-painful procedures in ch...
What is the current status of trial NCT03220880?
This trial is currently completed. The enrollment target is 578 participants. The study started on 2018-09-04. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03220880?
The interventions under investigation include: Intranasal dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT03220880?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.